Filing Flows › Medicinova (MNOV) › Q2 2026 › vs Q1 2026
Medicinova (MNOV) Q2 2026 vs Q1 2026 (quarter over quarter)
Medicinova's revenue rose $271K (+145%) from $187K in Q1 2026 to $458K in Q2 2026.
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $458K | $187K | $271K | +145% |
| Other income, net | $227K | $250K | −$22K | -9% |
| Net loss | $2.3M | $2.6M | −$272K | -11% |
| Costs & expenses | $3.0M | $3.0M | −$23K | -0.8% |
| Operating costs | $3.0M | $3.0M | −$23K | -0.8% |
| Research & development | $900K | $1.2M | −$300K | -25% |
| Sales & marketing | $141K | $170K | −$29K | -17% |
| General & admin | $1.8M | $1.6M | $240K | +15% |
| Other operating costs | $129K | $63K | $67K | +107% |
| Operating cash sources | $2.3M | $2.6M | −$272K | -11% |
| Depreciation & amortization | $5K | $4K | $1K | +18% |
| Share-based compensation | $177K | $408K | −$231K | -57% |
| Working capital & other | $212K | −$1.3M | $1.5M | — |
| Cash used in operations | $1.9M | $3.5M | −$1.6M | -45% |
| Net loss absorbed | $2.3M | $2.6M | −$272K | -11% |
Questions
How much did Medicinova's revenue grow quarter over quarter in Q2 2026?
Medicinova's revenue rose $271K (+145%) from $187K in Q1 2026 to $458K in Q2 2026.